CORSI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 288
EU - Europa 159
AS - Asia 95
Totale 542
Nazione #
US - Stati Uniti d'America 287
SG - Singapore 46
IE - Irlanda 40
SE - Svezia 37
CN - Cina 36
UA - Ucraina 19
DE - Germania 15
IT - Italia 15
GB - Regno Unito 9
TR - Turchia 8
BE - Belgio 7
FR - Francia 5
RU - Federazione Russa 4
IN - India 3
CZ - Repubblica Ceca 2
FI - Finlandia 2
VN - Vietnam 2
AT - Austria 1
CA - Canada 1
ES - Italia 1
HR - Croazia 1
RO - Romania 1
Totale 542
Città #
Chandler 63
Dublin 39
Singapore 38
Jacksonville 34
Ashburn 22
Dearborn 19
Princeton 16
Ann Arbor 11
Beijing 11
Santa Clara 10
Nanjing 9
Altamura 8
Boardman 7
Brussels 7
Izmir 7
Wilmington 6
New York 5
Munich 4
Southend 4
Washington 4
Cambridge 3
Chieti 3
Hebei 3
Brno 2
Dong Ket 2
Hangzhou 2
Helsinki 2
Jiaxing 2
Knoxville 2
Nanchang 2
Shenyang 2
Tianjin 2
Woodbridge 2
Changsha 1
Cormeilles-en-Parisis 1
Cosenza 1
Dallas 1
Eastpointe 1
Edinburgh 1
Guangzhou 1
Kunming 1
Las Vegas 1
Los Angeles 1
Madrid 1
Toronto 1
Vienna 1
Zagreb 1
Totale 367
Nome #
Mononucleosis-related fatigue: supplementary management with Robuvit®. 89
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 81
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 78
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 72
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 72
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 70
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 67
The Efficacy of Sulodexide in the Prevention of Postthrombotic Syndrome 58
Totale 587
Categoria #
all - tutte 2.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202096 0 0 0 2 21 13 17 7 16 4 16 0
2020/202137 2 3 9 0 0 12 1 0 1 2 0 7
2021/202235 0 2 1 13 0 0 0 2 2 0 5 10
2022/2023177 11 22 12 20 19 25 5 21 26 1 10 5
2023/202478 4 5 5 1 6 24 17 5 0 0 0 11
2024/202575 4 34 36 1 0 0 0 0 0 0 0 0
Totale 587